Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TOWR
2376
DELISTED
Tower International, Inc.
TOWR
| $1.59M | ﹤0.01% |
70,825
+41,125
| +138% | +$992K |
|
2377
Valhi
VHI
$394M
| $1.59M | ﹤0.01% |
44,400
-738
| -2% | -$29.3K |
|
|
FNGN
2378
DELISTED
Financial Engines, Inc.
FNGN
| $1.59M | ﹤0.01% |
+43,400
| New | +$1.73M |
|
2379
Arq
ARQ
$81.6M
| $1.58M | ﹤0.01% |
173,000
+112,400
| +185% | +$1.05M |
|
|
CORV
2380
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.58M | ﹤0.01% |
350,713
+97,300
| +38% | +$353K |
|
|
AMFW
2381
DELISTED
AMEC Foster Wheeler plc
AMFW
| $1.58M | ﹤0.01% |
263,300
-66,000
| -20% | -$443K |
|
|
MRT
2382
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $1.58M | ﹤0.01% |
+125,400
| New | +$1.5M |
|
2383
Ultralife
ULBI
$89.1M
| $1.58M | ﹤0.01% |
219,500
+69,400
| +46% | +$425K |
|
|
LUMO
2384
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.58M | ﹤0.01% |
23,878
+18,556
| +349% | +$2.3M |
|
2385
Gyre Therapeutics
GYRE
$638M
| $1.58M | ﹤0.01% |
45,290
+36,520
| +416% | +$1.31M |
|
2386
Aegon
AEG
$13.4B
| $1.58M | ﹤0.01% |
389,853
-117,960
| -23% | -$462K |
|
2387
Landmark Bancorp
LARK
$195M
| $1.58M | ﹤0.01% |
80,174
+6,515
| +9% | +$129K |
|
|
HEES
2388
DELISTED
H&E Equipment Services
HEES
| $1.57M | ﹤0.01% |
77,100
+67,700
| +720% | +$1.42M |
|
|
BEBE
2389
DELISTED
Bebe Stores Inc
BEBE
| $1.57M | ﹤0.01% |
264,230
+33,400
| +14% | +$159K |
|
2390
Larimar Therapeutics
LRMR
$384M
| $1.57M | ﹤0.01% |
37,258
+22,241
| +148% | +$1.14M |
|
|
BSF
2391
DELISTED
Bear State Financial, Inc.
BSF
| $1.56M | ﹤0.01% |
165,163
-17,311
| -9% | -$160K |
|
2392
Nicolet Bankshares
NIC
$3.65B
| $1.56M | ﹤0.01% |
28,500
+16,800
| +144% | +$845K |
|
2393
Webster Financial
WBS
$12.3B
| $1.54M | ﹤0.01% |
29,531
-205,600
| -87% | -$10.4M |
|
|
NWY
2394
DELISTED
New York & Co Inc
NWY
| $1.54M | ﹤0.01% |
1,117,500
+88,000
| +9% | +$135K |
|
|
LADR
2395
Ladder Capital
LADR
$1.24B
| $1.54M | ﹤0.01% |
114,930
+47,600
| +71% | +$682K |
|
|
ZAGG
2396
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.54M | ﹤0.01% |
+178,200
| New | +$1.42M |
|
|
GPIC
2397
DELISTED
Gaming Partners International Corporation
GPIC
| $1.54M | ﹤0.01% |
128,800
+700
| +0.5% | +$7.21K |
|
2398
DNOW Inc
DNOW
$2.44B
| $1.53M | ﹤0.01% |
95,300
-405,200
| -81% | -$6.9M |
|
2399
OFG Bancorp
OFG
$2.24B
| $1.53M | ﹤0.01% |
153,170
-85,700
| -36% | -$900K |
|
2400
Mueller Water Products
MWA
$3.98B
| $1.53M | ﹤0.01% |
130,800
-336,100
| -72% | -$3.86M |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.